MediPharm Labs Corp (MEDIF)
0.0628
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
MediPharm Labs 1 Year Total Returns (Daily): 7.35% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 7.35% |
| May 02, 2024 | -1.97% |
| May 01, 2024 | 0.58% |
| April 30, 2024 | 24.55% |
| April 29, 2024 | 2.13% |
| April 26, 2024 | 5.44% |
| April 25, 2024 | 0.49% |
| April 24, 2024 | 0.40% |
| April 23, 2024 | -0.36% |
| April 22, 2024 | -4.11% |
| April 19, 2024 | -17.75% |
| April 18, 2024 | -17.39% |
| April 17, 2024 | -13.97% |
| April 16, 2024 | -14.86% |
| April 15, 2024 | -18.29% |
| April 12, 2024 | 3.40% |
| April 11, 2024 | 9.09% |
| April 10, 2024 | 8.46% |
| April 09, 2024 | 9.79% |
| April 08, 2024 | 7.23% |
| April 05, 2024 | 17.16% |
| April 04, 2024 | 8.07% |
| April 03, 2024 | 15.58% |
| April 02, 2024 | 23.24% |
| April 01, 2024 | 26.37% |
| Date | Value |
|---|---|
| March 28, 2024 | 17.80% |
| March 27, 2024 | 18.48% |
| March 26, 2024 | 21.64% |
| March 25, 2024 | 10.91% |
| March 22, 2024 | 6.18% |
| March 21, 2024 | -8.68% |
| March 20, 2024 | -8.39% |
| March 19, 2024 | -8.61% |
| March 18, 2024 | -7.41% |
| March 15, 2024 | -8.99% |
| March 14, 2024 | -10.10% |
| March 13, 2024 | -6.66% |
| March 12, 2024 | -15.74% |
| March 11, 2024 | -13.49% |
| March 08, 2024 | -11.27% |
| March 07, 2024 | -14.55% |
| March 06, 2024 | -16.42% |
| March 05, 2024 | -14.87% |
| March 04, 2024 | -16.81% |
| March 01, 2024 | -20.64% |
| February 29, 2024 | -15.00% |
| February 28, 2024 | -18.28% |
| February 27, 2024 | -21.01% |
| February 26, 2024 | -19.81% |
| February 23, 2024 | -15.49% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.89%
Minimum
Jun 13 2022
262.7%
Maximum
Oct 29 2019
-40.23%
Average
-64.64%
Median
1 Year Total Returns (Daily) Benchmarks
| Acasti Pharma Inc | 10.17% |
| Aurinia Pharmaceuticals Inc | -56.37% |
| Edesa Biotech Inc | -40.91% |
| Lexaria Bioscience Corp | 93.21% |
| Xenon Pharmaceuticals Inc | 7.28% |